Immunomodulators for severe coronavirus disease-2019 in transplant patients: Do they increase the risk of secondary infection?

Mendoza, Maria A; Ranganath, Nischal; Chesdachai, Supavit; Yetmar, Zachary A; Razonable, Raymund; Abu Saleh, Omar

Mendoza, Maria A; Ranganath, Nischal; Chesdachai, Supavit; Yetmar, Zachary A; Razonable, Raymund; Abu Saleh, Omar.

Afiliação

Mendoza MA; Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Ranganath N; Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Chesdachai S; Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Yetmar ZA; Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Razonable R; Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Abu Saleh O; Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Transpl Infect Dis ; 25(2): e14050, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36852753

Assuntos

COVID-19; Coinfecção; Humanos; COVID-19/epidemiologia; SARS-CoV-2; Estudos Retrospectivos; Teste para COVID-19; Fatores Imunológicos/uso terapêutico; Adjuvantes Imunológicos; Transplantados

Palavras-chave

COVID-19; baricitinib; bone marrow transplant; secondary infections; solid organ transplant; tocilizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coinfecção / COVID-19 Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google